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As part of the life cycle of the pneumococcal phage Cp-7, the endolysin
Cpl-7 cleaves the glycosidic 1,4 bonds between N-acetylmuramic acid and
N-acetylglucosamine in the pneumococcal cell wall, resulting in bacterial lysis.
Recombinant Cpl-7 was overexpressed in Escherichia coli, purified and
crystallized using the vapour-diffusion method at 291 K. Diffraction-quality
tetragonal crystals of the catalytic module of Cpl-7 were obtained from a
mixture of PEG 3350 and sodium formate. The crystals belonged to space group
I422, with unit-cell parameters a = 127.93, b = 127.93, c = 82.07 A˚. Diffraction
data sets were collected to 2.4 A˚ resolution using a rotating-anode generator.
1. Introduction
Bacteriophages, or phages, are viruses that infect bacteria. Following
replication inside its bacterial host, the phage is faced with a problem:
it needs to exit the bacterium to disseminate its progeny. To solve this
problem, double-stranded DNA (dsDNA) phages have evolved a
lytic system to weaken the bacterial cell wall, resulting in bacterial
lysis. Phage lytic enzymes, or endolysins, are highly efficient mole-
cules that have been refined over millions of years for this exact
purpose (Fischetti, 2005). The Streptococcus pneumoniae bacterio-
phage Cp-7 (Podoviridae family) contains the cpl-7 gene which
encodes the lytic protein Cpl-7 (342 amino-acid residues; 38.4 kDa;
Fig. 1) possessing muramidase (lysozyme) activity (Garcı´a et al.,
1990).
The Cpl-7 lysozyme belongs to the GH25 family of glycosyl
hydrolases (http://www.cazy.org/fam/GH25.html); it binds to the
bacterial envelope and cleaves the glycosidic 1,4 bonds between
the N-acetylmuramic acid and N-acetylglucosamine moieties of the
glycan chains, breaking down the peptidoglycan (PG) backbone.
Most S. pneumoniae endolysins display a modular structure. In
addition to the catalytic module, they possess a choline-binding
module (CBM) which facilitates their anchorage to the choline-
containing teichoic acids of the S. pneumoniae cell wall (Garcı´a et al.,
1988). In turn, this CBM is formed by the repetition of a basic unit of
about 20 amino acids, which is also found in multiple tandem copies in
a large family of surface proteins (the choline-binding protein family)
from S. pneumoniae and its bacteriophages. Interestingly, Cpl-7 does
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Figure 1
Schematic representation of the modular structure of Cpl-7 endolysin. The catalytic
module belongs to glycosyl hydrolase family 25; the linker (black line) and the cell-
wall binding module, which is composed of three repeats, are also represented.
Residue numbers are indicated at the top.
not present such a choline-binding module, but instead contains a
putative cell-wall-binding module formed by three nearly identical
tandem repeats of 48 amino acids each (Fig. 1). This cell-wall-binding
module presents a completely different sequence to those of other
known peptidoglycan-binding motifs. Three complete choline-binding
proteins (CBP) have been structurally characterized to date, namely
Cpl-1 (Hermoso et al., 2003), Pce (Hermoso et al., 2005) and CbpF
(Molina et al., 2007), none of which possess an anchor motif similar to
that of Cpl-7.
The Cpl-1 lysozyme (which shares a similar catalytic module to that
of Cpl-7) and Pal amidase, which are produced by the Cp-1 and Dp-1
phages, respectively, act in a synergistic manner in a murine model
(Jado et al., 2003). Furthermore, using this mouse model it has
been demonstrated that Cpl-1 can eliminate colonization caused
by S. pneumoniae and prevent the development of otitis media
(McCullers et al., 2007). These results suggest that these active phage
lytic enzymes, termed enzybiotics, have a noticeable effect as anti-
microbial agents (Hermoso et al., 2007). Hence, knowledge of the
structure of these enzymes will be helpful in the establishment of a
novel enzybiotic treatment for streptococci-mediated diseases.
2. Experimental
2.1. Protein expression and purification
The full-length Cpl-7-coding gene was amplified by polymerase
chain reaction (PCR) from the pCP700 plasmid using sense (50-GGA-
ATTCATGGTTAAGAAAAATGATTTATTTGTAGACGTTG-30)
and antisense (50-CCCAAGCTTAAAATAGCTAGTAGAAAATT-
TCTACTAGCTTTTACTTGTTA-30) primers, in which the nucleo-
tides in bold are digestion sites for the restriction enzymes EcoRI and
HindIII, respectively. The resulting purified 1000 kb PCR product
was cloned into the expression vector pKLSLt (Manchen˜o & Angulo,
2009), rendering plasmid pKLSLt-Cpl-7, which was used to transform
competent Escherichia coli BL21 (DE3) cells. The expression vector
pKLSLt is based on pET28a(+) (Novagen, Germany) and incorpo-
rates the nucleotide sequence coding for LSLt, namely the -trefoil
module of the haemolytic lectin LSLa from the mushroom Laetiporus
sulphureus (Manchen˜o et al., 2005) followed by a sequence coding for
a linker stretch (ASSS) and a TEV (tobacco etch virus) endoprotease
cleavage site (ENLYFQG; Manchen˜o & Angulo, 2009). Cloning of
the nucleotide sequence coding for LSLt was performed between the
NcoI and EcoRI restriction sites of pET28a(+). For the production of
recombinant LSLt-Cpl-7 fusion protein, the appropriate recombinant
strain was cultured in Luria–Bertani broth at 310 K with aeration;
when the culture reached an OD600 of about 0.8 protein expression
was induced with 0.5 mM isopropyl -d-1-thiogalactopyranoside
(IPTG) and incubation was continued for 4 h. After centrifugation,
the cleared cell lysate was applied onto a Sepharose 4B affinity
column (GEHealthcare). After exhaustive washing with 20 mM Tris–
HCl pH 8.0 containing 0.1M NaCl buffer and 0.04%(w/v) sodium
azide, the fusion protein LSLt-Cpl-7 was eluted with 200 mM lactose
in 20 mM Tris–HCl pH 8.0 with 0.1M NaCl and 0.04%(w/v) sodium
azide. Fractions containing LSLt-Cpl-7 were pooled and dialyzed
against TEV digestion buffer [50 mM Tris–HCl pH 8.0 with 0.2M
NaCl and 0.04%(w/v) sodium azide]. The dialyzed sample was
concentrated using a 10 kDa cutoff protein concentrator (Amicon
YM-10) and digested with TEV protease (kindly provided by Roger
Williams at MRC, Cambridge) at a protein:TEV ratio of 80:1(w:w).
Cpl-7 was separated from the LSLt fusion tag by size-exclusion
chromatography on Superdex 75 (GE Healthcare). All purification
steps were performed at 277 K. The enzyme was then concentrated at
277 K using a 10 kDa cutoff protein concentrator (Amicon YM-10).
The final protein concentration was determined by UV–Vis absor-
bance measurements with a Nanodrop ND-1000 spectrophotometer
(Thermo Scientific), using a theoretical extinction coefficient of
68 425M1 cm1 at 280 nm.
2.2. Crystallization
A NanoDrop robot (Innovadyne Technologies Inc.) was used to
assay initial crystallization conditions using Crystal Screens I, II, Lite,
Index and SaltRx from Hampton Research and PACT Suite and
JCSG+ Suite from Qiagen. Initial assays were carried out by the
sitting-drop vapour-diffusion method at 291 K in Innovaplate SD-2
microplates (Innovadyne Technologies Inc.), mixing 250 nl protein
solution with 250 nl precipitant solution and equilibrating against
80 ml well solution. The stock protein was concentrated to 10 mg ml1
in 20 mM Tris–HCl pH 8.0 and 0.1M NaCl.
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Figure 2
Crystals of the catalytic module of Cpl-7 endolysin grown at 295 K in 0.2M sodium
formate, 20%(v/v) PEG 3350. The approximate dimensions of the crystals are
0.1  0.01  0.1 mm.
Figure 3
SDS–PAGE analysis of a Cpl-7 crystal. Lane 1, broad-range (BioRad) molecular-
weight markers (molecular weights are labelled on the left in kDa); lane 2,
dissolved crystal of Cpl-7; lane 3, purified Cpl-7 sample (38 kDa). The content of
the crystal is a partially cleaved Cpl-7 protein compatible with the catalytic module
of Cpl-7 (28 kDa). Silver staining was used for protein detection.
2.3. X-ray data collection and processing
X-ray diffraction data were collected at 120 K on an in-house
Kappa 2000 Bru¨ker–Nonius CCD detector using Cu K X-rays
generated by an FR591 Bru¨ker–Nonius rotating-anode generator
equipped with a double-mirror focusing system and operated at
45 kV and 100 mA. The crystal-to-detector distance was maintained
at 200 mm. Crystals were soaked for 10 s in a cryoprotectant solution
containing mother liquor and 30%(v/v) glycerol and were then flash-
cooled at 100 K in a nitrogen stream using a cryogenic system
controlled by a Cryostream Controller 700 (Oxford Cryosystems).
The images were processed and scaled using DENZO and SCALE-
PACK from the HKL-2000 suite (Otwinowski & Minor, 1997).
Intensities were converted to structure-factor amplitudes using
TRUNCATE (Collaborative Computational Project, Number 4,
1994).
3. Results and discussion
A systematic search for crystallization conditions yielded crystals
from 0.2M sodium formate and 20% PEG 3350 (condition No. 63
of the JCSG+ Suite). Crystals reached maximum dimensions of
0.1 0.01 0.1 mm in four months (Fig. 2). Because of the long wait
for crystals to appear, we decided to run one of the crystals on SDS–
PAGE followed by silver staining (Switzer et al., 1979) to assay the
crystal composition (Fig. 3). The gel clearly indicated that the protein
inside the crystal was partially cleaved, presenting a molecular weight
that was compatible with the catalytic module of Cpl-7 (28 kDa).
Despite the small size of the crystals, an X-ray data set was collected
to 2.4 A˚ resolution using an in-house rotating-anode source and
presented good-quality patterns (Fig. 4). The crystals belonged to the
tetragonal system, space group I422, with unit-cell parameters
a = b = 127.93, c = 82.07 A˚. X-ray data-collection statistics are
summarized in Table 1. Specific volume calculations for the catalytic
module of Cpl-7 suggested the presence of one molecule in the
asymmetric unit and a solvent content of 59.50% (VM = 3.03 A˚
3 Da1;
Matthews, 1968).
Structure solution was initiated with the molecular-replacement
method using the structure of the catalytic module of Cpl-1 from
bacteriophage Cp-1 (Hermoso et al., 2003; PDB code 1h09) as the
initial model. This module shows 84% sequence homology to the
catalytic module of Cpl-7 (Garcı´a et al., 1990). Molecular replacement
was performed using the MOLREP program (Vagin & Teplyakov,
1998) with reflections in the 15.0–3.5 A˚ resolution range. A single and
unambiguous solution for the rotation and translation functions was
obtained, which yielded a final correlation coefficient of 0.64 and an R
factor of 0.38.
Inspection of the preliminary electron-density map revealed the
presence of the complete catalytic module of Cpl-7 but the absence of
the cell-wall-binding module. Obviously, the degradation of native
Cpl-7 within the crystallization drop, leading to crystallization of the
catalytic module, may explain the time that was required for crystal
growth. Structural refinement of this module of Cpl-7 is currently in
progress.
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Figure 4
Typical X-ray diffraction pattern of a crystal of the catalytic module of Cpl-7
(oscillation range 1).
Table 1
Data-collection statistics for the Cpl-7 crystal.
Values in parentheses are for the highest resolution shell.
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